tbuckley/cabot-search huggingface dataset:
American Journal of Surgery, New York
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Placenta previa percreta with bladder invasion
Authors: M. L. Collins
Journal: JAMA (1978)

PLACENTA percreta is a rare but potentially catastrophic obstetric condition, with a high incidence of fetal death and maternal mortality and morbidity. First reported in 1900, only 37 cases had been documented by 1970. Placenta percreta with bladder invasion is even more uncommon, with only four cases previously described.<sup>1-4</sup> We present a case of placenta previa percreta with bladder invasion resulting in massive hemorrhage and prolonged shock. <h3>Report of a Case</h3> A 31-year-old woman, gravida 4, para 3, registered for prenatal care at ten weeks of pregnancy. She had undergone three previous cesarean sections without difficulty. She weighed 125 kg and was mildly hypertensive. At 12 weeks of pregnancy, she bled about 100 ml of bright red blood during one day; otherwise, her prenatal course was uneventful. At term, routine repeated cesarean section was begun under spinal anesthesia. The anterior aspect of the uterus was covered by huge varicosities
The Complete Anas of Thomas Jefferson.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Terminology in Table 2
Authors: Maité Garrouste-Orgeas, Sébastien Bailly, Jean-François Timsit
Journal: JAMA (2019)

Matthew D. F. McInnes, MD; David Moher, PhD; Brett D. Thombs, PhD; Trevor A. McGrath, BSc; Patrick M. Bossuyt, PhD; and the PRISMA-DTA Group; Tammy Clifford, PhD; Jérémie F. Cohen, MD, PhD; Jonathan J. Deeks, PhD; Constantine Gatsonis, PhD; Lotty Hooft, PhD; Harriet A. Hunt, MSc; Christopher J. Hyde, PhD; Daniël A. Korevaar, MD, PhD; Mariska M. G. Leeflang, PhD; Petra Macaskill, PhD; Johannes B. Reitsma, MD, PhD; Rachel Rodin, MD, MPH; Anne W. S. Rutjes, PhD; Jean-Paul Salameh, BSc; Adrienne Stevens, MSc; Yemisi Takwoingi, PhD; Marcello Tonelli, MD, SM; Laura Weeks, PhD; Penny Whiting, PhD; Brian H. Willis, MD, PhD
WHO: Stop Making Smoking Glamorous
Authors: Joan Stephenson
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A prospective, comparative evaluation of the implementation of Good Clinical Practice (GCP) guidelines for preventing pain during invasive investigations in cancer patients (pts)
Authors: M. Di Palma, H. Salcedo, P. Gaudebout, J. Marie, P. Franchi, F. Belal, J. Mauve, K. Slimane, I. Gasquet, J.-L. Misset
Journal: Journal of Clinical Oncology (2004)

8055 Background: Iatrogenic pain is a concern for oncologists, especially pain related to diagnostic or therapeutic procedures which are numerous and repeated for cancer pts. In most instances these examinations are planned, therefore pain-preventing protocols could be used. Methods: the aim of our study was to promote the use of these protocols as GCP and to measure the effect of their implementation on the pain and discomfort perceived by pts. We considered 5 situations: bone marrow biopsy, bone marrow aspiration, ascitis drainage, pleural drainage and arterial puncture for gazometry. We compared a center G- where no global guidelines were available and a center G+ where physicians and nurses were educated about pain and specific guidelines edited for each situation. Guidelines included pts reception, information about procedure, anxiolytics, transdermal prilocaine /lidocaine, local percutaneous anesthesia. Main endpoint was the comparison of pain levels between the 2 centers (as measured by a 11-point visual analogic scale VAS) during the procedure, global satisfaction of pts and physicians. Results: 239 pts were included in G-, 223 in G+. All pts had some medication to prevent pain: in G- pts had only local anesthesia. In G+ guidelines were effectively used in 50% of pts: for other pts anxiolytic and /or prilocaine/lidocaine was omitted. Overall pain was significantly lower in G+ (mean VAS 2.6 vs 3.2, p=0.008). A difference was found even when guidelines were not applied. This could be explained by a better awareness of pain as an issue in G+. Pain was not correlated with tumor type or extent, gender, age. Conclusions: Education of physicians and pts information are effective for reducing pain during invasive investigations in cancer pts. This means not only to use adequate anesthetic procedures but also to take in account pts stress. No significant financial relationships to disclose.
Cardiovascular disease
Authors: J. M. Gore
Journal: JAMA (1992)

Thrombolytic therapy continues to be the standard of care for patients with evolving acute myocardial infarction, improving both short- and long-term outcome.<sup>1,2</sup>Despite its benefit, thrombolytic therapy is administered to only a minority of patients with evolving myocardial infarction. Only one third of all patients with acute myocardial infarction meet the current therapeutic guidelines for thrombolytic therapy, and it has been estimated that only half of the eligible patients actually receive treatment. Several factors may be involved in the limited use of thrombolytic therapy. Some physicians may avoidthrombolytic therapy because of their concern about the risk of hemorrhagic stroke. Fatal and nonfatal central nervous system bleeding is the most devastating complication of thrombolytic therapy and occurs in 0.2% to 1% of patients.<sup>3</sup>Although the incidence of hemorrhagic stroke has increased with the advent of thrombolytic therapy, the incidence of embolic stroke has decreased. The total incidence of strokes in patients treated with thrombolytic
Correction
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Author Name
Authors: Preeti Mehrotra, Andi Shane, Aaron Milstone
Journal: JAMA Pediatrics (2016)

In Reply We appreciate the response by Curley and Meyer to our Viewpoint titled "Family-Centered Care and High-Consequence Pathogens: Thinking Outside the Room" 1 and the continued dialogue regarding family-centered care and high-consequence pathogens.We agree with the assertion that family-centered care and parental presence remain a vital component of pediatric health care delivery.As such, we take issue with the contention that infection control practices that promote safety are "inhumane."As suggested, we do not advocate for sweepingly generalized efforts; we advocate for physical separation only with suspected or confirmed cases of pathogens of high consequence-when the risk of transmissibility is great or unknown and when infection has a high probability of severe morbidity and mortality.In these circumstances, we believe that the safety of our patients, their family members, and health care workers should remain the utmost priority.Our primary goal for the care of a child infected with a high-consequence pathogen is to provide socially supportive and safe medical care that results in a rapid recovery, allowing for an efficient reunion of the patient with his or her family.Attachment theory and stress-coping models explain the detrimental psychological effects of separation.We concur that parent-patient and parent-nursing relationships are mutually enriched when parents participate in patient care.However, when the development of these relationships interferes with personal and public safety, infection prevention and control experts must promote safety and public health.Hospitals have no experience with "just-in-time" training of non-health care workers, and even trained health care workers frequently self-contaminate while doffing personal protective equipment. 2 The technical challenges of parental personal protective equipment training, resource allocation, and meeting increased pediatric staffing needs, as well as potential culture and language barriers, are serious complexities even with all the advances of the 21st century.We believe that these considerations should preserve the safety of family members and health care workers in the face of uncertainty and undue risk.Our initial recommendations are based on current 21st-century capabilities and limitations.However, we need to capitalize on these opportunities to advance our understanding and abilities so that we can better reevaluate these decisions in the future.The core value of our position is that safety and family centeredness are not mutually exclusive concepts-safety is a priority that need not come at the expense of practicing familycentered care.We ask child life experts, ethicists, chaplains, nurses, physicians, and the authors of the letter to think beyond the walls of the patient room in understanding that family centeredness is not simply a matter of physical presence.Rather, it is a way of providing care that is effective, compas-sionate, and safe.In promoting this brand of care, we believe we are putting family first.
Development of Medical Countermeasures to Chemical Terrorism—The NIEHS’s Involvement in a Government-Wide Research Effort
Authors: Dennis Lang
Journal: Environmental Health Perspectives (2005)

T he attacks of September 11, 2001, using airplanes, followed closely by the biologic attacks using anthrax spores placed in letters, have illustrated how vulnerable our society is to such acts of terrorism.Since these events, the NIH has led the national research effort focused on the development of medical countermeasures to treat civilian mass casualties.The NIH has received more than $1.5 billion annually, starting in FY 2002, to fund research focused primarily on development of products to diagnose, treat, or prevent bacterial and viral infectious diseases and toxemias that could result from bioterrorist attacks.These initial efforts, focused on infectious agents, have been led by the National Institute of Allergy and Infectious Diseases.In FY 2005, the NIH was given an additional $47.1 million to establish a radiation and nuclear medical countermeasures program to identify products to treat civilians injured by a dirty bomb or nuclear attack.Similar plans are under way to initiate research in FY 2006 to develop products to diagnose and treat victims of a chemical attack.As part of the planning for an expanded effort related to chemical agents, the NIEHS and the National Institute on Neurological Diseases and Stroke co-sponsored, in FY 2005, an administrative supplement program to existing grants.The intent of these supplements is to develop improved detection, diagnosis, and treatment strategies for likely chemical threat agents.As a result of this program, NIEHS has funded six supplements for a total of $450,000.The NIEHS supplements went to: »Paul Bishop and Joseph Caruso, University of Cincinnati, to work on increasing the sensitivity of methods they have developed for detecting hydrolysis products of nerve agents and to extend their analysis to spiked food and water samples »Brian Day, National Jewish Medical and Research Center, to test the ability of lipoic acid, dihydrolipoic acid, and thioredoxin to reverse or prevent pulmonary injury caused by sulfur mustard »Richard DiGiulio and Ted Slotkin, Duke University, to study the developmental neurotoxicity of nerve agents and to assess some possible protective treatment strategies »Clem Furlong, University of Washington, to attempt to increase the activity of human PON1 enzyme to levels sufficient to protect against paraoxon exposure in a mouse model.If successful, he will test the modified enzyme's ability to protect against exposure to sarin, soman, and VX agents in the same mouse model.»Bruce Hammock and Ian Kennedy, University of California, Davis, to work on the development of miniaturized sensors for use in detecting botulinum toxin, ricin, and abrin »Cary Pope, Oklahoma State University, to study the differential toxicity of the organophosphorus pesticides chlorpyrifos and parathion, as well as the threat agents sarin and soman, and their inhibition of acetylcholinesterase and the accumulation of acetylcholine in a cannulated rat brain model
Micropatterning Different Cell Types with Microarray Amplification of Natural Directional Persistence
Authors: Kyu‐Shik Mun, Girish Kumar, Carlos C. Co, Chia‐Chi Ho
Journal: Advanced Healthcare Materials (2017)

Adv. Healthcare Mater. 2012, 2, 1200141 The information about the time that micrographs were captured at in Figure 3a was not correct. The corrected Figure 3 listed below: The authors apologize for any inconvenience caused.
The Psychiatrist, the Treatment of Chronic Renal Failure, and the Prolongation of Life: II
Authors: HARRY S. ABRAM
Journal: American Journal of Psychiatry (1969)

Chronic hemodialysis offers a unique opportunity to study man's adaptation to an artificial organ and to highlight some new areas in which the psychiatrist's knowledge of interpersonal relations and intrapersonal conflicts can be useful. This presentation emphasizes the phases in the patient's adaptation to dialysis and the changes in body image associated with dependence on an artificial organ. It also touches upon the role psychiatry can play in understanding man's response to the life-prolonging measures increasingly provided him by advancing medical and surgical techniques.
Proteolytic Enzyme Activity and the Role of DNA in Cystic Fibrosis Sputum
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medical Educational Requirements in the United States
Journal: JAMA (1892)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Case for Certification
Authors: J Struthers
Journal: BMJ (1970)

T4le Society for Relief of Widows and Orphans of Medical Men, founded in 1788, distributed £6,045 to the widows and or- phans of subscribers in 1969.Membership of the Society, a registered charity, is open to male registered medical practitioners who, at th,e time of election, are resident within 60 miles of Charing Cross.Experi- ence shows, states the annual report, that in spite of superannuation schemes there is still a pressing need for insurance of the kind the Society provides.When a doctor dies young, his wife and family can be left in a tragically precarious position.The assets of the Society were over £140,000 at the end of 1969.
ACTION OF RADIUM AND ROENTGEN RAYS ON NORMAL AND DISEASED LYMPHOID TISSUE
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Statin Strikeout
Authors: Jeffrey M. Drazen, Annetine C. Gelijns
Journal: New England Journal of Medicine (2014)

The results of two randomized, controlled trials, supported by the U.S. National Institutes of Health, in which inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, commonly known as statins, were tested for efficacy in sepsis-associated acute respiratory distress syndrome (ARDS)1 and in chronic obstructive pulmonary disease (COPD)2 are now reported in the Journal. The rationale of the trials was based largely on observational data showing that patients with these conditions who were taking statins had better outcomes than patients who were not. Both trials were stopped by the data and safety monitoring boards before the projected enrollment was completed because no . . .